Stay updated with breaking news from Masimo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As a result of an ITC order arising from a patent dispute with Masimo, Apple will halt the sales of its Series 9 and Ultra 2 smartwatches in the USA starting December 21.
The tech giant is facing a patent dispute with Masimo Corp. over the technology that enables the blood oxygen feature on the watches.
Apple plans to stop selling the banned watches online on Thursday in this country and remove them from its physical stores by December 24
The discontinuation is a response to a ruling by the U.S. International Trade Commission, which found that Apple's blood oxygen feature infringed on the patent rights of medical technology company Masimo. The removal of these devices from Apple's website is scheduled for 3 p.m. ET Thursday, and they will no longer be available in Apple retail stores after Sunday. Apple plans to challenge the decision, expressing concern about the potential impact on users relying on the watches' safety and health features.
Apple stock is struggling to break through the $200 barrier as it contends with potential bad news around sales of both its Watch and iPhones.